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ABSTRACT
Background. Several independent studies found 
a linkage between diabetic kidney disease and chro-
mosome 3q22. Following studies were not able to 
found a genetic polymorphism in the chromosome 
3q22 region which was associated with diabetic kidney 
disease and which could explain the observed linkage. 
The SCL9A9 gene coding for the sodium/hydrogen 
exchanger 9 is located in the critical region on chromo-
some 3q22. Genetic variants of the SCL9A9 gene might 
be involved in the abnormal kinetics of erythrocyte 
sodium-lithium countertransport observed in patients 
with diabetic kidney disease. The aim of the study was 
to check the association between genetic polymorphi-
sms of the SCL9A9 gene and diabetic kidney disease.
Material and methods. We collected 61 patients 
with diabetic kidney disease and 63 patients with 
normoalbuminuria after at least 15 years of known 
diabetes duration. Peripheral blood was drawn and 
DNA was extracted from leukocytes. Fragments of 
the SCL9A9 gene were amplified by PCR and digested 
by specific restriction enzymes. Altogether 3 poly-
morphisms were genotyped: rs17594058 in intron 1, 
rs7641634 in intron 2 and rs6763202 in exon 8. The 
genotype frequency was compared between patients 
with and without diabetic kidney disease.
Results. There was no difference in the genoty-
pe frequency for analyzed polymorphisms in the 
SCL9A9 gene between patients with and without dia-
betic kidney disease.
Conclusions. The genetic variants of the SCL9A9 gene 
localized in the critical region on chromosome 3q22 are 
not associated with diabetic kidney disease. (Diabet. 
Klin. 2014; 3, 1: 17–21)
Key words: diabetic kidney disease, genetic 
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STRESZCZENIE
Wstęp. W kilku niezależnych badaniach stwierdzo-
no sprzężenie pomiędzy fragmentem chromosomu 
3q22 a cukrzycową chorobą nerek. Kolejne badania 
nie były w stanie znaleźć polimorfizmu genetyczne-
go zlokalizowanego na chromosomie 3q22, który 
wykazywałby związek z cukrzycową chorobą nerek 
i tłumaczyłby wcześniej stwierdzone sprzężenie. Gen 
SCL9A9 kodujący antyporter sodowo-protonowy 
izoformę 9 jest zlokalizowany w krytycznym regionie 
na chromosomie 3q22. Warianty genetyczne w genie 
SCL9A9 mogą być odpowiedzialne za odmienną kine-
tykę transportu sodowo-litowego obserwowanego 
w erytrocytach u chorych z cukrzycową chorobą nerek. 
Celem badania była analiza związku pomiędzy polimor-
fizmami genu SCL9A9 a cukrzycową chorobą nerek.
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Materiał i metody. Do badania włączono 61 chorych 
z cukrzycową chorobą nerek oraz 63 chorych z prawid-
łowym wydalaniem albumin w moczu po co najmniej 
15 latach trwania cukrzycy. Od każdego chorego pobra-
no krew obwodową i z leukocytów wyizolowano DNA. 
Fragmenty genu SCL9A9 namnażano w reakcji PCR 
i trawiono specyficznymi enzymami restrykcyjnymi. 
W sumie przeprowadzono genotypowanie 3 polimorfi-
zmów: rs17594058 w intronie 1, rs7641634 w intronie 2 
oraz rs6763202 w egzonie 8. Porównano częstość 
występowania genotypów pomiędzy chorymi z i bez 
cukrzycowej choroby nerek.
Wyniki. Nie stwierdzono różnic w częstotliwości ge-
notypów badanych polimorfizmów genu SCL9A9 po-
między chorymi z i bez cukrzycowej choroby nerek.
Wnioski. Warianty genetyczne w genie SCL9A9 zloka-
lizowanym w krytycznym regionie na chromosomie 
3q22 nie wykazują związku z cukrzycową chorobą 
nerek. (Diabet. Klin. 2014; 3, 1: 17–21)
Słowa kluczowe: cukrzycowa choroba nerek, 
predyspozycja genetyczna, chromosom 3q22
Introduction
Epidemiological studies indicated a genetic 
predisposition to diabetic kidney disease [1, 2]. 
Two independent studies found a linkage between 
diabetic kidney disease and region on chromosome 
3q22 [3, 4]. Both of those studies used the same 
family model for linkage analysis based on sib-pairs 
concordant for type 1 diabetes, but discordant for 
diabetic kidney disease.
Several studies found an increased sodium-lithium 
countertransport activity in red cells of patients with 
insulin-dependent diabetes and diabetic kidney disease. 
The etiology of increased sodium-lithium countertrans-
port activity in red cells in patients with diabetic kidney 
disease was not found [5, 6]. Increased activity of one 
of the isoforms of sodium/hydrogen exchanger was 
suspected to be associated with that phenotype. Two 
isoforms were analyzed, but no association was found 
between increased sodium-lithium countertransport 
activity in red cells and sodium/hydrogen exchanger 
1 and 3. The SLC9A9 gene coding sodium/hydrogen 
exchanger 9 is localized on chromosome 3q22 in the 
critical region linked with diabetic kidney disease. The 
association between genetic variants of the sodium/hy-
drogen exchanger 9 gene and diabetic kidney disease 
has not been analyzed. The role of the sodium/hydro-
gen exchanger 9 in the etiology of increased sodium-
-lithium countertransport activity in red cells in patients 
with diabetic kidney disease is also not known.
There is a strong difference in predisposition to dia-
betic kidney disease among different ethnic groups. The 
lower risk for diabetic kidney disease is observed in 
Caucasian and the highest in African-American and 
Native Indian. The difference in incidence of diabetic 
kidney disease may be explained both by genetic drift 
or adaptive evolution. In a recent report, 101 regions 
of the human genome were identified with very strong 
evidence of a recent selective sweep in adaptive evolu-
tion [7]. One of them is the 5’ end of the SLC9A9 gene 
on chromosome 3q22 with a strong selective sweep in 
European-American and Chinese.
The aim of the study was to analyze the association 
between diabetic kidney disease and genetic variants 
in the SLC9A9 gene.
Patients and methods
The study included 61 diabetic patients with 
diabetic kidney disease (albumin/creatinine ratio, 
ACR ≥ 30 mg/g) and 63 diabetic patients with normo-
albuminuria (ACR < 30 mg/g) after at least 15 years 
of known diabetes duration. Patients without diabetic 
retinopathy were excluded from the diabetes kidney 
disease group. 31 patients in the diabetic kidney disease 
group had moderately increased albuminuria (ACR 
30–300 mg/g) and 30 had severely increase albuminuria 
(ACR > 300 mg/g). We excluded also from the diabetic 
kidney disease group patients with increased numbers 
of erythrocytes and leukocytes in urine. For each pa-
tient, 2.7 ml of blood were collected from peripheral 
vein. Erythrocytes were lyzed with lysis buffer and DNA 
was extracted from leukocytes using the Genomic Midi 
AX 20 set (A&A Biotechnology, Gdynia, Poland). Three 
polymorphisms localized in the SLC9A9 gene were 
genotyped: rs17594058 in intron 1, rs 7641634 in 
intron 2 and rs6763202 in exon 8. Following primers 
and restriction enzymes were used for genotyping:
 — rs17594058 F 5’-ggg act taa gag gga cat Ctt a-3’, 
rs17594058 R1 5’-cag cag agt gta cct gca ct-3’ 
(MolBiol, Poznan, Poland), HpyF3I (Fermentas, 
Lithuania);
 — rs7641634 F 5’-cta ggt ctg ttt agt ggt cGc att-3’, 
rs7641634 R1 5’-aag aca gga cag agt agc ag-3’ 
(MolBiol, Poznan, Poland), Mva1269I (Fermentas, 
Lithuania);
 — rs6763202 R 5’-gtt tcc agc atc ggg aac Gc-3’; 
rs6763202 F1 5’-gag cta tca tca cca gat cag-3’ 
(MolBiol, Poznan, Poland), Bsh1236I (Fermentas, 
Lithuania).
Underlined nucleotide indicates a DNA mismatch 
introduced into the primer to provide a specific restric-
tion site. The DNA fragment containing analyzed poly-
morphism was amplified by PCR. Amplified fragments 
www.dk.viamedica.pl
Irmina Korzeniewska-Dyl i wsp., SLC9A9 gene and diabetic kidney disease
19
were digested with restriction enzyme recognizing only 
one of two alleles. PCR products were separated by 3% 
agarose gel electrophoresis.
Genotype frequency was compared between pa-
tients with and without diabetic kidney disease.
Statistical analysis was performed using software 
R version 2.15.2 (The R Foundation for Statistical 
Computing). The R package ‘genetics’ was used to 
calculate linkage disequilibrium between genotyped 
polymorphisms (http://rgenetics.org).
The Ethics Committee of the Medical University of 
Lodz approved the study protocol.
Results
The clinical characteristics of patients analyzed in 
the study is presented in Table 1. Patients with diabetic 
kidney disease had by design higher urine albumin 
excretion than those without diabetic kidney. They had 
shorter known duration of diabetes and higher serum 
creatinine concentration. Patients with increase urine 
albumin excretion had to have retinopathy to be inclu-
ded into the diabetic kidney disease group. 
The genotype frequency is presented in Table 2. 
There were no significant differences in the genotype 
frequency between patients with and without diabetic 
kidney disease for the rs17594058 polymorphism in the 
intron 1, the rs7641634 polymorphism in the intron 2 
and the rs6763202 polymorphism in the exon 8 of the 
SLC9A9 gene.
The linkage disequilibrium between rs17594058, 
rs7641634 and rs6763202 polymorphisms in the 
SLC9A9 gene is presented in Table 3. There were a strong 
linkage disequilibrium between the rs17594058 poly-
morphism in the intron 1 and the rs7641634 poly-
morphism in the intron 2 (D’ = 0,99). The linkage 
disequilibrium between the rs7641634 polymorphism 
Table 1. Clinical characteristics of patients with diabetic kidney disease (DKD) and without diabetic kidney disease 
(No DKD). Data are presented as median (minimum and maximum)
DKD No DKD p value
n 61 63
Gender (female/male) 31/30 32/31 NS
Diabetes (type 1/type 2) 14/47 25/38 NS
Age (years) 62 (24–100) 56 (21–90) NS
Diabetes duration (years) 15 (1–42) 20 (15–40) < 0,01
ACR [mg/g] 21 (32–6799) 6 (0–29) < 0,001
Serum creatinine [µmol/L] 122 (67–555) 94 (68–197) < 0,001
HbA1c (%) 8.0 (5.4–13.5) 7.5 (5.4–12.2) NS
BMI [kg/m2] 29.9 (21.7–62.7) 26.4 (19.0–41.0) NS
Insulin treatment (yes/no) 55/6 59/4 NS
Triglycerides [µmol/L] 1.7 (0.6–4.8) 1.3 (0.4–4.7) NS
Total cholesterol [µmol/L] 4.89 (2.1–9.1) 4.6 (2.4–7.7) NS
Smoking (yes/no) 18/43 11/52 NS
ACEI or AT1B (yes/no) 40/21 30/33 NS
Retinopathy (yes/no) 61/0 26/37 < 0.001
Table 2. Genotype frequency in patients with diabetic kidney disease (DKD) and without diabetic kidney disease (No DKD)
rs17594058 (intron 1) GG AG AA p value
No DKD (n = 63) 22 (35%) 33 (52%) 8 (13%)
DKD (n = 61) 25 (41%) 29 (48%) 7 (11%) NS
rs7641634 (intron 2) CC CT TT p value
No DKD (n = 63) 40 (63%) 20 (32%) 3 (5%)
DKD (n = 61) 41 (67%) 16 (26%) 4 (7%) NS
rs6763202 (exon 8) TT CT CC p value
No DKD (n = 63) 34 (54%) 27 (43%) 2 (3%)
DKD (n = 61) 24 (39%) 33 (54%) 4 (7%) NS
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in the intron 2 and the rs6763202 polymorphism in the 
exon 8 was weak (D’ = 0,52). No linkage disequilibrium 
was observed between the rs17594058 polymorphism 
in the intron 1 and the rs6763202 polymorphism in the 
exon 8 (D’ = 0,04).
Discussion
We did not find an association between diabetic 
kidney disease and polymorphisms in the SLC9A9 gene. 
The SLC9A9 was a good candidate gene in the critical 
region on the chromosome 3q22 linked to diabetic 
kidney disease. The question stays open which genetic 
variant in the critical region on chromosome 3q22 is 
associated with diabetic kidney disease.
Chromosome 3q22 was linked with diabetic kidney 
disease [3, 4]. Several studies tried to find a genetic 
marker for diabetic kidney disease in the 3q22 region 
[8–11]. More than 3000 single nucleotide polymorphi-
sm localized in the critical 3q22 region were analyzed 
in 1822 type 1 diabetes patients with diabetic kidney 
disease and 1874 type 1 diabetes patients without dia-
betic kidney disease [12]. One of the analyzed genetic 
variants the rs1866813 polymorphism was associated 
with diabetic kidney disease. The observed association 
between the rs1866813 polymorphism and diabetic 
kidney disease seems to be too weak to explain previo-
usly observed linkage [3, 4]. The association between 
the rs1866813 polymorphism and diabetic kidney 
disease has not been confirmed in Polish population 
[13]. Confirmatory reports from other populations 
are also missing. Only one whole-genome association 
study was published for diabetic kidney disease [14]. 
In that study no polymorphism in the critical region of 
the 3q22 polymorphism was found to be associated 
with diabetic kidney disease [14]. 
The role of the sodium/hydrogen exchanger 9 has 
not been well explained. In one study chromosomal 
aberration affecting the SLC9A9 gene and in another 
one genetic variants in the SLC9A9 gene were asso-
ciated with an attention-deficit/hyperactivity disorder 
symptoms [15, 16]. Sodium/hydrogen exchanger 
9 shows high homology with other sodium/hydrogen 
exchanger including the sodium/hydrogen exchanger 
1 and 3 previously analyzed in diabetic kidney disease. 
Increased erythrocyte sodium lithium countertransport 
observed in patients with diabetic kidney disease co-
uld not be inhibited by amiloride [17]. The role of the 
sodium/hydrogen exchanger 1 and 3 in the etiology 
of increased sodium lithium countertransport is less 
probable, because they can be inhibited by amiloride 
[17]. The effect of amiloride on inhibition of the so-
dium/hydrogen exchanger 9 and the presents of the 
sodium/hydrogen exchanger 9 in human erythrocytes 
has not been examined yet. The question stays open 
what is responsible for the phenotype of increased 
sodium-lithium countertransport activity in red cells 
in diabetic kidney disease.
One of the reasons why we analyzed the 
SLC9A9 gene is a strong selective sweep in Euro-
pean-American and Chinese at the 5’ end of the 
SLC9A9 gene on chromosome 3q22. This selective sweep 
might explain why there are significant difference in 
predisposition to diabetic kidney disease among diffe-
rent ethnic groups. Negative results of the study did not 
confirm the primary hypothesis that genetic variants in 
the SLC9A9 gene might explain association between 
predisposition to diabetic kidney disease and ethnicity.
In conclusion, we were not able to prove that the 
SLC9A9 gene coding the sodium/hydrogen exchanger 
9 is associated with genetic predisposition to diabetic 
kidney disease.
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